Smolak_2024_J.Pharmacol.Exp.Ther__

Reference

Title : Target cell activation of a structurally novel NLRP3 inhibitor NT-0796 enhances potency - Smolak_2024_J.Pharmacol.Exp.Ther__
Author(s) : Smolak P , Nguyen M , Diamond C , Wescott H , Doedens JR , Schooley K , Snouwaert JN , Bock MG , Harrison D , Watt AP , Koller BH , Gabel CA
Ref : Journal of Pharmacology & Experimental Therapeutics , : , 2024
Abstract : Smolak_2024_J.Pharmacol.Exp.Ther__
ESTHER : Smolak_2024_J.Pharmacol.Exp.Ther__
PubMedSearch : Smolak_2024_J.Pharmacol.Exp.Ther__
PubMedID: 38253384

Related information

Citations formats

Smolak P, Nguyen M, Diamond C, Wescott H, Doedens JR, Schooley K, Snouwaert JN, Bock MG, Harrison D, Watt AP, Koller BH, Gabel CA (2024)
Target cell activation of a structurally novel NLRP3 inhibitor NT-0796 enhances potency
Journal of Pharmacology & Experimental Therapeutics :

Smolak P, Nguyen M, Diamond C, Wescott H, Doedens JR, Schooley K, Snouwaert JN, Bock MG, Harrison D, Watt AP, Koller BH, Gabel CA (2024)
Journal of Pharmacology & Experimental Therapeutics :